Buscar en
Enfermedades Infecciosas y Microbiología Clínica (English Edition)
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica (English Edition) Tinea corporis of rare aetiology in patient with immunosuppressive treatment
Journal Information
Vol. 41. Issue 3.
Pages 187-188 (March 2023)
Visits
203
Vol. 41. Issue 3.
Pages 187-188 (March 2023)
Diagnosis at first sight
Full text access
Tinea corporis of rare aetiology in patient with immunosuppressive treatment
Tinea corporis de extraña etiología en paciente con tratamiento inmunosupresor
Visits
203
Javier Gutiérrez-Ballesterosa,
Corresponding author
, Teresa Nebreda-Mayorala, M. Carmen Gutiérrez-Rodríguezb, Ana M. Martínez-Garcíaa
a Servicio de Microbiología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
b Servicio de Dermatología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Full Text
Case report

This was a 32-year-old woman with a 10-year history of ulcerative colitis treated with infliximab and mesalazine. She lived on a farm with horses, although she had no direct contact with them. The patient was referred to the Dermatology clinic with a very itchy erythematous, scaly plaque with scattered macules and papules inside on her right forearm, which had been growing along the edge, with a circular or ring-like appearance, for a year (Fig. 1). Previously, she had been treated with high-potency topical corticosteroids for 6 months, with the lesion becoming worse. Skin scales were taken for mycology culture and treatment was started with oral terbinafine 250 mg/ h and topical flutrimazole 1% every 12 h for 2 months.

Figure 1.

Image of the anterior and posterior aspect of the forearm.

(0.1MB).

Skin flakes were cultured on Sabouraud-chloramphenicol agar (Becton–Dickinson, Tullastrasse, Germany) and Sabouraud-cycloheximide agar (Becton–Dickinson, Tullastrasse, Germany) and incubated at 30°C aerobically. After 6 days of incubation, the growth of two colonies of a filamentous fungus with a flat, powdery, yellowish front and a smooth, bright yellow back was observed on the Sabouraud-cycloheximide agar plate (Fig. 2a and b). Microscopic examination using lactophenol blue staining revealed pyridiform microconidia arranged along the hyphae and lanceolate, rough, septate (6–9 septa) thin-walled macroconidia emerging from the central or final part of the hyphae (Fig. 2c), characteristics with which it was identified as Nanizzia praecox, based on De Hoog et al.1 Identification was corroborated by MALDI/TOF mass spectrometry (Bruker®, Billerica, United States) after protein extraction in a liquid medium described by Cassagne et al.2 with a score of 2.21 for N. praecox.

Figure 2.

(a) Front view of colony of N. praecox. (b) Back view of colony of N. praecox. (c) Observation under contrast microscopy of hyphae and septate macroconidia of N. praecox. Lactophenol blue staining ×400.

(0.19MB).
Clinical course

After an initial worsening, the lesion slowly improved. At 13 days, the patient still had considerable itching and erythema. At 2 months, the lesion was virtually resolved (Fig. 3), but the itching and some erythema persisted, so it was decided to continue treatment with oral itraconazole 50 mg/24 h for 14 days and topical flutrimazole until full resolution.

Figure 3.

Image of the anterior aspect of the arm after 2 months of treatment.

(0.19MB).
Comments

N. praecox is a dermatophyte belonging to the Arthrodermataceae family, classified until 2017 in the genus Microsporum (M. praecox). It is a geophilic and zoophilic fungus closely associated with equine environments, which rarely causes infection in humans.3,4 To date, fewer than 40 cases have been described in the literature. Uhrlaß et al.5 reported three cases of tinea corporis caused by N. praecox in five years, in which two of the patients had had direct contact with horses. Alanio et al.6 reported another case of a female horse rider with tinea corporis in which the aetiological agent was M. praecox. In the case we describe here, our patient did not have direct contact with horses, but she did live in an equine environment, so indirect transmission through the soil and contaminated materials seems the most likely route of infection, as the characteristic geophilic properties of this dermatophyte enable it to remain in the environment without the need for an animal reservoir.4 The main limitation of this work is not having had a PCR technique to confirm the identification. However, the study by Hamal et al.7 included 196 filamentous fungi, including dermatophytes, where identification by MALDI/TOF associated with a previous extraction of proteins in a liquid medium had a correlation rate at the species level close to 90% with sequencing results. The results obtained by Hamal et al.7 in conjunction with the case we describe here, show that using two complementary techniques affordable for most laboratories, like mass spectrometry and macro/microscopic identification, results are comparable to those obtained with more complex molecular techniques, which are less accessible to most Microbiology services. In terms of treatment, topical antifungals are usually sufficient in demarcated non-inflammatory lesions; in more severe cases, combining with a systemic antifungal (terbinafine, griseofulvin or azoles) is usually necessary.4 The lesion usually resolves within a month with appropriate treatment.5,6 In this case, the resolution was slower (>2 months) probably because the patient was receiving long-term immunosuppressive therapy for the treatment of her disease. To sum up, N. praecox is a pathogen to be considered in patients with lesions compatible with tinea corporis and/or tinea capitis and who live in environments with direct or indirect contact with horses.

References
[1]
G.S. De Hoog, J. Guarro, J. Gené.
Atlas of clinical fungi.
4th ed., Centraal- bureau voor Schimmel cultures/Universitat Rovira I Virgili, (2020), pp. 1155-1157
[2]
C. Cassagne, S. Ranque, A.C. Normand, P. Fourquet, S. Thiebault, C. Planard, et al.
Mould routine identification in the clinical laboratory by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
[3]
G.S. De Hoog, K. Dukik, M. Monod, A. Packeu, D. Stubbe, M. Hendrickx, et al.
Toward a novel multilocus phylogenetic taxonomy for the dermatophytes.
[4]
K. Dukik, G.S. de Hoog, J.B. Stielow, J. Freeke, B.G. van den Ende, V.A. Vicente, et al.
Molecular and phenotypic characterization of Nanizzia (Arthrodermataceae).
Mycopathologia, 185 (2020), pp. 9-35
[5]
S. Uhrlaß, P. Mayser, R. Schwarz, D. Koch, C. Krüger, I. Korfmann, et al.
Dermatomycoses due to Nannizzia praecox (formerly Microsporum praecox) in Germany: case reports and review of the literature.
Mycopathologia, 183 (2018), pp. 391-398
[6]
A. Alanio, S. Romand, D. Penso-Assathiany, F. Foulet, F. Botterel.
Microsporum praecox: molecular identification of a new case and review of the literature.
Mycopathologia, 171 (2011), pp. 61-65
[7]
P. Hamal, A. Vavrova, J. Mrazek, L. Svobodova.
Identification of filamentous fungi including dermatophytes using MALDI-TOF mass spectrometry.
Folia Microbiol, 67 (2022), pp. 55-61
Copyright © 2022. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos